$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000117184322005576 Filed on August 10, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$6.516M	$6.513M	$6.508M
YoY Change	-2.35%	7.0%	13.92%
Cost Of Revenue	$4.184M	$4.240M	$4.067M
YoY Change	16.29%	16.13%	29.32%
Gross Profit	$2.332M	$2.273M	$2.441M
YoY Change	-24.16%	-6.69%	-4.95%
Gross Profit Margin	35.79%	34.9%	37.51%
Selling, General & Admin	$2.379M	$2.258M	$2.133M
YoY Change	20.09%	16.63%	-1.75%
% of Gross Profit	102.02%	99.34%	87.38%
Research & Development	$328.0K	$357.0K	$318.0K
YoY Change	34.43%	21.84%	13.57%
% of Gross Profit	14.07%	15.71%	13.03%
Depreciation & Amortization	$597.0K	$611.0K	$628.0K
YoY Change	-23.56%	-7.84%	-8.99%
% of Gross Profit	25.6%	26.88%	25.73%
Operating Expenses	$2.707M	$2.615M	$2.451M
YoY Change	21.66%	17.32%	0.0%
Operating Profit	-$375.0K	-$342.0K	-$10.00K
YoY Change	-144.12%	-265.22%	-108.55%
Interest Expense	-$8.000K	-$8.000K	-$9.000K
YoY Change	-33.33%	-38.46%	-10.0%
% of Operating Profit
Other Income/Expense, Net	-$8.000K	-$9.000K	$66.00K
YoY Change	-110.67%		-571.43%
Pretax Income	-$383.0K	-$351.0K	$56.00K
YoY Change	-141.41%	-269.57%	-45.63%
Income Tax	-$286.0K	-$13.00K	$17.00K
% Of Pretax Income			30.36%
Net Earnings	-$97.00K	-$338.0K	$39.00K
YoY Change	-113.13%	-352.24%	-53.01%
Net Earnings / Revenue	-1.49%	-5.19%	0.6%
Basic Earnings Per Share	-$0.02	-$0.06	$0.01
Diluted Earnings Per Share	-$0.02	-$0.06	$0.01
COMMON SHARES
Basic Shares Outstanding	5.626M	5.610M	5.590M
Diluted Shares Outstanding	5.638M	5.610M	5.646M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.458M	$1.790M	$2.127M
YoY Change	75.71%	-32.48%	-2.88%
Cash & Equivalents	$3.500M	$1.800M	$2.100M
Short-Term Investments
Other Short-Term Assets	$1.510M	$1.722M	$1.033M
YoY Change	-45.17%	-33.13%	-45.63%
Inventory
Prepaid Expenses
Receivables	$4.953M	$4.405M	$4.704M
Other Receivables	$803.0K	$2.985M	$2.661M
Total Short-Term Assets	$10.72M	$10.90M	$10.53M
YoY Change	-8.12%	-7.11%	-0.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.976M	$8.697M	$9.441M
YoY Change	9.32%	8.81%	9.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$843.0K	$851.0K	$842.0K
YoY Change	-4.53%	0.24%	-4.54%
Total Long-Term Assets	$9.754M	$9.548M	$10.44M
YoY Change	-18.45%	-25.7%	-24.07%
TOTAL ASSETS
Total Short-Term Assets	$10.72M	$10.90M	$10.53M
Total Long-Term Assets	$9.754M	$9.548M	$10.44M
Total Assets	$20.48M	$20.45M	$20.97M
YoY Change	-13.35%	-16.83%	-14.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$857.0K	$598.0K	$722.0K
YoY Change	91.29%	-45.64%	-34.9%
Accrued Expenses	$3.974M	$3.264M	$3.045M
YoY Change	23.3%	72.7%	94.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$360.0K	$461.0K	$563.0K
YoY Change	-48.28%	-33.48%	-18.52%
Total Short-Term Liabilities	$6.176M	$5.297M	$5.324M
YoY Change	15.61%	13.96%	22.96%
LONG-TERM LIABILITIES
Long-Term Debt	$380.0K	$453.0K	$526.0K
YoY Change	-48.65%	-85.37%	-83.91%
Other Long-Term Liabilities	$2.200M	$2.457M	$2.657M
YoY Change	-31.97%	-29.6%	-29.34%
Total Long-Term Liabilities	$380.0K	$453.0K	$526.0K
YoY Change	-48.65%	-85.37%	-83.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.176M	$5.297M	$5.324M
Total Long-Term Liabilities	$380.0K	$453.0K	$526.0K
Total Liabilities	$8.756M	$8.514M	$8.507M
YoY Change	-8.85%	-25.78%	-26.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.73M	-$10.24M	-$9.511M
YoY Change	40.3%	22.09%	11.59%
Common Stock	$34.17M	$33.89M	$33.69M
YoY Change	2.33%	2.03%	1.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M	$10.08M	$10.08M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	$668.0K	$668.0K	$668.0K
Shareholders Equity	$11.72M	$11.94M	$12.46M
YoY Change
Total Liabilities & Shareholders Equity	$20.48M	$20.45M	$20.97M
YoY Change	-13.35%	-16.83%	-14.0%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$97.00K	-$338.0K	$39.00K
YoY Change	-113.13%	-352.24%	-53.01%
Depreciation, Depletion And Amortization	$597.0K	$611.0K	$628.0K
YoY Change	-23.56%	-7.84%	-8.99%
Cash From Operating Activities	$2.334M	$317.0K	$345.0K
YoY Change	-701.55%	-51.0%	-183.54%
INVESTING ACTIVITIES
Capital Expenditures	-$91.00K	-$29.00K	$10.00K
YoY Change	33.82%	-14.71%	42.86%
Acquisitions
YoY Change
Other Investing Activities	-$7.000K	-$25.00K	$7.000K
YoY Change	-86.0%	-238.89%	-170.0%
Cash From Investing Activities	-$98.00K	-$54.00K	-$36.00K
YoY Change	-16.95%	237.5%	-38.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-568.0K	-600.0K	-$174.0K
YoY Change	220.9%	246.82%	1.75%
NET CHANGE
Cash From Operating Activities	2.334M	317.0K	$345.0K
Cash From Investing Activities	-98.00K	-54.00K	-$36.00K
Cash From Financing Activities	-568.0K	-600.0K	-$174.0K
Net Change In Cash	1.668M	-337.0K	$135.0K
YoY Change	-344.22%	-173.58%	-121.0%
FREE CASH FLOW
Cash From Operating Activities	$2.334M	$317.0K	$345.0K
Capital Expenditures	-$91.00K	-$29.00K	$10.00K
Free Cash Flow	$2.425M	$346.0K	$335.0K
YoY Change	-857.81%	-49.19%	-179.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	118000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20867000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19659000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6294000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6257000
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5626000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5589000
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	36000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	393000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-338000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	36000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	393000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-299000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-299000	usd
	us-gaap	Net Income Loss NetIncomeLoss	217000	usd
CY2022Q2	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	0	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1000
	dei	Document Type DocumentType	10-Q
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	599000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	307000	usd
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01720
	dei	City Area Code CityAreaCode	978
	dei	Local Phone Number LocalPhoneNumber	206-8220
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2457000	usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-13738
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	58-1701987
	dei	Entity Address Address Line1 EntityAddressAddressLine1	289 Great Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Acton
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	984000	usd
	dei	Security12b Title Security12bTitle	Common stock. $0.005 par value
	dei	Trading Symbol TradingSymbol	PMD
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5297000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5830000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	453000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10242000	usd
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5626196
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1790000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1992000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4405000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4116000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1722000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1499000	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2985000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2678000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	10902000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	10285000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5555000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6691000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	851000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	864000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	160000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3142000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3552000	usd
CY2022Q2	us-gaap	Assets Assets	20450000	usd
CY2021Q4	us-gaap	Assets Assets	21552000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	598000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	994000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3264000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3188000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	461000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	664000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	974000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2880000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	8514000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	9309000	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	31000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	33863000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	33478000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-351000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	207000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9550000	usd
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-295000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11936000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12243000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20450000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21552000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6513000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6087000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13021000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11800000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4240000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3651000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8307000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6796000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2273000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	2436000	usd
	us-gaap	Gross Profit GrossProfit	4714000	usd
	us-gaap	Gross Profit GrossProfit	5004000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1445000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1280000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2772000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2809000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	813000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	656000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1619000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1298000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	357000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	293000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	675000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	573000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2615000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2229000	usd
	us-gaap	Operating Expenses OperatingExpenses	5066000	usd
	us-gaap	Operating Expenses OperatingExpenses	4680000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-342000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	207000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-352000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	324000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	57000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	310000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-338000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	134000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-299000	usd
	us-gaap	Net Income Loss NetIncomeLoss	217000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	-8000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-90000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	12461000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	238000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11936000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12243000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	417000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11936000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	12812000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	169000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	134000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13115000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	386000	usd
	us-gaap	Net Income Loss NetIncomeLoss	217000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13115000	usd
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	1239000	usd
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	1353000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	488000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	470000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	467000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	27000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	417000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	386000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	289000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	615000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	223000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1661000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	307000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	44000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-396000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	523000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-511000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-508000	usd
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	76000	usd
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	89000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	662000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	237000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	63000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	70000	usd
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	18000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-32000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	349000	usd
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	343000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	393000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-774000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-343000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-202000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-182000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1992000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2833000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1790000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2651000	usd
	us-gaap	Interest Paid Net InterestPaidNet	19000	usd
	us-gaap	Interest Paid Net InterestPaidNet	28000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	568000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	575000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	78000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	193000	usd
	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	0	usd
CY2021Q2	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	800000	usd
	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	1600000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1800000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	238000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	169000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	417000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	386000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	574000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.23
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	83000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.07
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.07
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5610000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5627000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	572000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M6D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	70000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	519000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.89
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5610000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5539000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5600000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5538000
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	88000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5600000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5621000
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	733000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	589000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3100000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3400000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	232000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	501000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	518000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1133000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1061000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	553000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	460000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3725000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	294000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3431000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	974000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2457000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3431000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6513000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6087000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13021000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11800000	usd

Files In Submission

Name	View Source	Status
0001171843-22-005576-index-headers.html	Edgar Link	pending
0001171843-22-005576-index.html	Edgar Link	pending
0001171843-22-005576.txt	Edgar Link	pending
0001171843-22-005576-xbrl.zip	Edgar Link	pending
ex_405774.htm	Edgar Link	pending
ex_405775.htm	Edgar Link	pending
ex_405776.htm	Edgar Link	pending
ex_405777.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pmd-20220630.xsd	Edgar Link	pending
pmd20220630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
pmd-20220630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
pmd-20220630_pre.xml	Edgar Link	unprocessable
pmd-20220630_def.xml	Edgar Link	unprocessable
pmd20220630_10q_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pmd-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2022 Q3 Form 10-Q Financial Statement

#000117184322005576 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2022 Q3 Form 10-Q Financial Statement

#000117184322005576 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi